Study Details
Full Title
CONNECT 1906: Phase 2 trial of a novel peptide vaccine (PEP-CMV) targeting CMV antigen for newly diagnosed pediatric high-grade glioma (HGG) and diffuse intrinsic pontine glioma (DIPG) and recurrent medulloblastoma (MB).
Principal Investigator
Daniel
Landi
Protocol Number
PRO00109336
NCT ID
NCT05096481
Phase
II
Enrollment Status
Open to Enrollment